Cite
Chemokine Receptor 2–targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial
MLA
Hannah Luehmann, et al. “Chemokine Receptor 2–targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial.” American Journal of Respiratory and Critical Care Medicine, vol. 203, Jan. 2021, pp. 78–89. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a9aba66372ad9a17457625ed13cfe080&authtype=sso&custid=ns315887.
APA
Hannah Luehmann, Amber Salter, Benjamin D. Humphreys, Jeffrey J. Atkinson, Gyu Seong Heo, Yongjian Liu, Adrian Shifren, Cedric Mpoy, Christophe Combadière, Michelle Hoelscher, Sean P. Gunsten, Daniel Kreisel, Ethan C. Lee, Buck E. Rogers, Shuchi Guo, Tonya D. Russell, Jiehong Pan, Jeffrey R. Koenitzer, Delphine L. Chen, … Robert J. Gropler. (2021). Chemokine Receptor 2–targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial. American Journal of Respiratory and Critical Care Medicine, 203, 78–89.
Chicago
Hannah Luehmann, Amber Salter, Benjamin D. Humphreys, Jeffrey J. Atkinson, Gyu Seong Heo, Yongjian Liu, Adrian Shifren, et al. 2021. “Chemokine Receptor 2–targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial.” American Journal of Respiratory and Critical Care Medicine 203 (January): 78–89. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a9aba66372ad9a17457625ed13cfe080&authtype=sso&custid=ns315887.